OpenAI Foundation to fund 'biotech's lost archive' from failed companies
The nonprofit announced it will pay for high-quality scientific datasets sourced from bankrupt biotech firms to accelerate medical AI breakthroughs.
What to know
- OpenAI Foundation will fund acquisition of scientific datasets from failed biotech companies through bankruptcy proceedings.
- The initiative aims to create 'biotech's lost archive'—regulatory filings, manufacturing strategies, and safety data—to accelerate medical AI breakthroughs.
- AI hyperscalers face pressure to justify nearly $1.1 trillion in projected spending through 2027, requiring extraordinary productivity gains to break even by 2030.
“By bidding at bankruptcy proceedings, she argued, it might be possible to obtain detailed regulatory filings, manufacturing strategies and safety data, creating what she called 'biotech's lost archive.'”
MIT Technology Review · MIT Technology Review ↗
OpenAI Foundation Funder of biotech data initiativeRuxandra Teslo Policy analyst and originator of the conceptJessica Wachter Finance professor, University of Pennsylvania
How it unfolded 1 development · click the chart to see its coverage articlesposts
-
1
OpenAI Foundation announces funding for biotech data initiative
The OpenAI Foundation, the nonprofit parent of OpenAI, announced it will fund Teslo's idea, paying to create 'high-quality scientific datasets' from failed biotech companies.
“The OpenAI Foundation, the nonprofit parent of OpenAI, announced this week that it will fund her idea, paying to create 'high-quality scientific datasets.'”
— MIT Technology Review -
first by MIT Tech Review, 11d ago
-
-
background
Ruxandra Teslo proposes using failed biotech data for medical AI — Policy analyst Ruxandra Teslo posted an idea to supercharge medical AI systems by acquiring data from bankrupt biotech companies through bankruptcy proceedings, creating what she called 'biotech's lost archive.'